Company news

Grace Therapeutics, Inc. news in 2025

Grace Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference

November 17, 2025

Grace Therapeutics Announces Second Quarter 2026 Financial Results, Provides Business Update

November 13, 2025

Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting

November 11, 2025

Grace Therapeutics Secures Approximately $4.0 Million through Common Warrant Exercises Following Acceptance of New Drug Application for GTx-104 for formal FDA Review

October 23, 2025

Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting

September 22, 2025

Grace Therapeutics Granted Sixth U.S. Patent Covering I.V. Dosing Regimen for GTx-104

September 18, 2025

Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference

September 4, 2025

Grace Therapeutics Announces U.S. Food and Drug Administration Acceptance for Review of New Drug Application for GTx-104

August 27, 2025

Grace Therapeutics Announces First Quarter 2026 Financial Results, Provides Business Update

August 12, 2025

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

June 25, 2025

Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update

June 23, 2025

Grace Therapeutics to Participate in the 2025 BIO International Conference

June 13, 2025

Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104

April 9, 2025

Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

February 25, 2025

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

February 12, 2025

Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH

February 9, 2025

Decks in 2025